• Allergan reports success in late-stage acne trials pharmatimes
    March 29, 2017
    Dublin, Ireland-based drugmaker Allergan and US partner Paratek Pharmaceuticals have reported that two Phase III trials assessing sarecycline for the treatment of moderate to severe ...
PharmaSources Customer Service